Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Specimen Handling 6Tamoxifen 3Starch 1Standard of Care 1Sentinel Lymph Node Biopsy 1Restraint, Physical 1Radiotherapy 1Radiosurgery 1Probiotics 1Practice Guidelines as Topic 1Omacor 1Methods 1Mastectomy, Subcutaneous 1Laser Therapy 1Genetic Testing 1Follow-Up Studies 1Diet Therapy 1Diet 1Chromatin Immunoprecipitation Sequencing 1Cannabidiol 1Bone Density 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Breast Carcinoma In Situ × Omacor × Clear all
NCT06195306 2026-05-20

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

National Cancer Institute (NCI)

Phase 2 Recruiting
66 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡